Abiomed’s quarterly revenue increases 34 percent, led by strong Impella sales growth

Tim Casey | | Cardiovascular Business | Economics

Abiomed’s revenue increased 34 percent to $114.7 million during the third fiscal quarter of 2017 compared with the same time period last year.

Meanwhile, its GAAP net income increased from $0.23 per diluted share in the third fiscal quarter of 2016 to $0.34 per share in the third fiscal quarter of 2017.

Abiomed announced the results in a news release on Jan. 26.

Most of the company’s revenue came from sales of its Impella heart pumps. During the quarter, Abiomed reported $109.2 million in Impella sales, a 35 percent increase during the same period last year.

Abiomed had $100.3 million in Impella sales in the U.S. and $8.9 million in Impella sales outside of the U.S., an increase of 34 percent and 47 percent, respectively. The company said that U.S. patient usage increased 32 percent, while most of the non-U.S. revenue came from Germany.

During the quarter, 20 hospitals made initial purchases of Impella 2.5 heart pumps, 49 hospitals made initial purchases of Impella CP heart pumps and 8 hospitals made initial purchases of the Impella RP heart pumps.

At the end of the quarter, which was Dec. 31, 2016, 1,119 sites had Impella 2.5 heart pumps, 972 sites had Impella CP heart pumps and 120 sites had Impella RP heart pumps.

From the third fiscal quarter of 2016 to the third fiscal quarter of 2017, Abiomed’s gross margin decreased from 85.1 percent to 83.4 percent, while its operating margin increased from 20.4 percent to 22.2 percent.

Abiomed expects fiscal year 2017 revenue in the range of $440 to $445 million, which would represent an increase of 34 percent to 35 percent from fiscal year 2016. The company projects fiscal year 2017 operating margin in the range of 18 percent to 20 percent.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."